Eltrombopag for secondary failure of platelet recovery post-allogeneic hematopoietic stem cell transplant in children. (opent nieuw venster)

Ali S, Gassas A, Kirby-Allen M, Krueger J, Ali M, Schechter T

Bron‎: Pediatr Transplant 2017;21(6):e13017.

Geïndexeerd‎: PubMed 28653480

DOI‎: 10.1111/petr.13017

https://www.ncbi.nlm.nih.gov/pubmed/28653480 (opent nieuw venster)

The role of interleukin-11 to prevent chemotherapy-induced thrombocytopenia in patients with solid tumors, lymphoma, acute myeloid leukemia and bone marrow failure syndromes. (opent nieuw venster)

Bhatia M, Davenport V, Cairo MS.

Bron‎: Leuk Lymphoma 2007;48(1):9-15.

Geïndexeerd‎: PubMed 17325843

DOI‎: 10.1080/10428190600909115

https://www.ncbi.nlm.nih.gov/pubmed/17325843 (opent nieuw venster)

Recombinant human interleukin 11 and bacterial infection in patients with haematological malignant disease undergoing chemotherapy: a double-blind placebo-controlled randomised trial. (opent nieuw venster)

Ellis M, Zwaan F, Hedström U, Poynton C, Kristensen J, Jumaa P, Wassell J, al-Ramadi B.

Bron‎: Lancet 2003;361(9354):275-80.

Geïndexeerd‎: PubMed 12559860

https://www.ncbi.nlm.nih.gov/pubmed/12559860 (opent nieuw venster)

Romiplostim for immune thrombocytopenia in neuroblastoma patients receiving chemotherapy. (opent nieuw venster)

Fassel H, Bussel JB, Roberts SS, Modak S

Bron‎: J Pediatr Hematol Oncol 2019;41(4):e257-9.

Geïndexeerd‎: PubMed 29683946

DOI‎: 10.1097/MPH.0000000000001187

https://www.ncbi.nlm.nih.gov/pubmed/29683946 (opent nieuw venster)

Romiplostim for therapy-related thrombocytopenia in pediatric malignancies. (opent nieuw venster)

Jacobson AE, Shah N, Setty BA

Bron‎: Pediatr Blood Cancer 2017;64(8):e26473.

Geïndexeerd‎: PubMed 28150377

DOI‎: 10.1002/pbc.26473

http://www.ncbi.nlm.nih.gov/pubmed/28150377 (opent nieuw venster)

Eltrombopag for delayed platelet recovery and secondary thrombocytopenia following allogeneic stem cell transplantation in children. (opent nieuw venster)

Li S, Wu R, Wang B, Fu L, Zhu G, Zhou X, Ma J, Zhang L, Qin M

Bron‎: J Pediatr Hematol Oncol 2019;41(1):38-41.

Geïndexeerd‎: PubMed 30080752

DOI‎: 10.1097/MPH.0000000000001263

https://www.ncbi.nlm.nih.gov/pubmed/30080752 (opent nieuw venster)

Romiplostim for secondary thrombocytopenia following allogeneic stem cell transplantation in children. (opent nieuw venster)

Maximova N, Zanon D, Rovere F, Maestro A, Schillani G, Paparazzo R

Bron‎: Int J Hematol 2015;102(5):626-32.

Geïndexeerd‎: PubMed 26084627

DOI‎: 10.1007/s12185-015-1821-1

https://www.ncbi.nlm.nih.gov/pubmed/26084627 (opent nieuw venster)

Recombinant human erythropoietin reduces the need for erythrocyte and platelet transfusions in pediatric patients with sarcoma: a randomized, double-blind, placebo-controlled trial. (opent nieuw venster)

Porter JC, Leahey A, Polise K, Bunin G, Manno CS

Bron‎: J Pediatr 1996;129(5):656-60.

Geïndexeerd‎: PubMed 8917229

DOI‎: 10.1016/s0022-3476(96)70145-2

https://www.ncbi.nlm.nih.gov/pubmed/8917229 (opent nieuw venster)

Chemotherapy induced thrombocytopenia in pediatric oncology. (opent nieuw venster)

Tamamyan G, Danielyan S, Lambert MP

Bron‎: Crit Rev Oncol Hematol 2016;99:299-307.

Geïndexeerd‎: PubMed 26811139

DOI‎: 10.1016/j.critrevonc.2016.01.005

https://www.ncbi.nlm.nih.gov/pubmed/26811139 (opent nieuw venster)

Oncological management of pediatric cancer patients belonging to Jehovahs Witnesses: a two-institutional experience report. (opent nieuw venster)

Tenenbaum T, Hasan C, Kramm CM, Janssen G, Laws HJ, Wessalowski R, Bode U, Göbel U

Bron‎: Onkologie 2004;27(2):131-7.

Geïndexeerd‎: PubMed 15138344

DOI‎: 10.1159/000076901

https://www.ncbi.nlm.nih.gov/pubmed/15138344 (opent nieuw venster)

Low-dose interleukin-11 in patients with bone marrow failure: update of the M. D. Anderson Cancer Center experience. (opent nieuw venster)

Tsimberidou AM, Giles FJ, Khouri I, Bueso-Ramos C, Pilat S, Thomas DA, Cortes J, Kurzrock R.

Bron‎: Ann Oncol 2005;16(1):139-45.

Geïndexeerd‎: PubMed 15598951

DOI‎: 10.1093/annonc/mdi007

https://www.ncbi.nlm.nih.gov/pubmed/15598951 (opent nieuw venster)

Safety and cost effectiveness of a 10 x 10(9)/L trigger for prophylactic platelet transfusions compared with the traditional 20 x 10(9)/L trigger: a prospective comparative trial in 105 patients with acute myeloid leukemia. (opent nieuw venster)

Wandt H, Frank M, Ehninger G, Schneider C, Brack N, Daoud A, Fackler-Schwalbe I, Fischer J, Gäckle R, Geer T, Harms P, Löffler B, Ohl S, Otremba B, Raab M, Schönrock-Nabulsi P, Strobel G, Winter R, Link H

Bron‎: Blood 1998;91(10):3601-6.

Geïndexeerd‎: PubMed 9572994

https://www.ncbi.nlm.nih.gov/pubmed/9572994 (opent nieuw venster)